Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

Jubilant Wins Relief: Allahabad HC Bars Pharma Firms from Using Its Drug Dossier

Susmita Roy2 Nov 2025 2:00 PM IST

New Delhi: In a significant ruling reinforcing copyright protection over pharmaceutical data, the Allahabad High Court has dismissed two appeals filed...

$MSN Labs Secures SEC Nod for Phase III Trial of Vibegron 75 mg, Excluding Refractory OAB Patients$

MSN Labs Secures SEC Nod for Phase III Trial of Vibegron 75 mg, Excluding Refractory OAB Patients

Susmita Roy2 Nov 2025 12:30 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has approved MSN Laboratories to conduct a...

Nearly 50% of Drug Inspector Posts Vacant at CDSCO, Reveals RTI Response

Susmita Roy1 Nov 2025 10:22 PM IST

New Delhi: Nearly 250 Drug Inspector posts remain vacant across the regulatory and medical device divisions of the Central Drugs Standard Control...

Boehringer Ingelheim, CDR-Life enter into new agreement to develop autoimmune disease molecule

Boehringer Ingelheim Told to File Separate Phase IV Trial Plan for Empagliflozin

Susmita Roy1 Nov 2025 5:42 PM IST

New Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has directed Boehringer Ingelheim India to...

Health Ministry Revises BA/BE Study Rules: Minimum Sample Size Set at 18

Health Ministry Drafts Rule to Debar Pharma Applicants Submitting Fake or Misleading Documents

Susmita Roy31 Oct 2025 7:51 PM IST

New Delhi: In a major regulatory move aimed at tightening compliance and accountability within India's pharmaceutical licensing framework, the...

One Label, One Rule: Centre Harmonises Legal Metrology Norms with Medical Device Standards

Susmita Roy31 Oct 2025 7:35 PM IST

New Delhi: In a significant regulatory move aimed at harmonizing labelling standards and reducing compliance overlap, the Department of Consumer...

Cipla, Hetero win bid to supply widely prescribed diabetes drug in China

CDSCO Panel Seeks Anesthesiology Expert Review for AIIMS Raipur Trial on Gabapentin, Melatonin, Clonidine FDC

Susmita Roy31 Oct 2025 7:26 PM IST

New Delhi: After reviewing a clinical trial proposal submitted by Dr Pratibha R Mudgal from AIIMS Raipur, involving a fixed-dose combination of...

Delhi HC Restrains Use of CALDIMUST Trademark Deceptively Similar to Mankind's CALCIMUST

Susmita Roy30 Oct 2025 10:10 PM IST

New Delhi: The Delhi High Court has granted an ex-parte ad-interim injunction restraining Carens Pharmaceuticals from manufacturing or selling...

No More Offline Filings: CDSCO Mandates Submission of Post-Approval Changes for Cell and Gene Therapy Trial via SUGAM Portal

Susmita Roy30 Oct 2025 1:18 PM IST

New Delhi: In a major regulatory development aimed at strengthening transparency and efficiency in India's clinical trial oversight, the Central Drugs...

USFDA concludes inspection at Dr Reddys Labs Srikakulam API facility

FSSAI Bar on Dr Reddy's Nutraceutical Put on Hold: Delhi HC Awaits Regulatory Hearing Outcome

Susmita Roy29 Oct 2025 9:52 PM IST

New Delhi: The Delhi High Court on Tuesday granted interim relief to Dr. Reddy's Laboratories Limited and its associated petitioners in a dispute with...

Pulse Pharma Gets CDSCO Panel Nod to Manufacture, Market Aripiprazole Oral Solution

Susmita Roy29 Oct 2025 2:46 PM IST

New Delhi: In a recent development, the Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has...

Zydus Lifesciences bags tentative USFDA nod for cancer drug Olaparib

MP FDA Moves Rs 320-Crore Proposal to CDSCO, FSSAI to Upgrade Drug, Food Testing Labs

Susmita Roy29 Oct 2025 2:41 PM IST

Bhopal: In the wake of the Chhindwara cough syrup tragedy, the Food and Drug Administration (FDA) of Madhya Pradesh has submitted two major proposals...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok